ReviewJournal of hematology & oncology2012
Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases.
Véronique Gelsi-Boyer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
159 papers cite itlatest 60 shown
this paperpooled ittrialcites it